Skip to main content
SpringerLink
Log in

Neoplasms of the Kidney

  • Chapter
Essentials of Anatomic Pathology

Abstract

The category of globally accepted neoplasms of the kidney continues to expand. Recognition of new entities is very important for care of patients and their families. For example, some new entities, such as clear cell papillary renal cell carcinoma and t(6;11) translocation carcinoma, exhibit indolent behavior; others, such as SDHB renal cell carcinomas, are remarkably aggressive, and their correct diagnosis establishes a guarded prognosis and impacts family members as well. It is hoped that this chapter will assist the reader in navigating the diagnostic pitfalls involved in establishing an accurate diagnosis for the many different types of renal neoplasms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Amin MB, MacLennan GT, Paraf F, et al. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol. 2009;33:384–92.

    Article  PubMed  Google Scholar 

  • Aydin H, Chen L, Cheng L, et al. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol. 2010;34:1608–21.

    PubMed  Google Scholar 

  • Bostwick DG, Cheng L. Urologic surgical pathology. 3rd ed. Philadelphia, PA: Elsevier/Saunders; 2014.

    Google Scholar 

  • Brunelli M, Eble JN, Zhang S, et al. Gains of chromosomes 7, 17, 12, 16 and 20, and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod Pathol. 2003a;16:1053–9.

    Article  PubMed  Google Scholar 

  • Brunelli M, Eble JN, Zhang S, et al. Metanephric adenoma lacks the gain of chromosomes 7 and 17 and loss of Y which are typical of papillary renal cell carcinoma and adenoma. Mod Pathol. 2003b;16:1060–3.

    Article  PubMed  Google Scholar 

  • Brunelli M, Eble JN, Zhang S, et al. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol. 2005;18:161–9.

    Article  CAS  PubMed  Google Scholar 

  • Brunelli M, Gobbo S, Cossu-Rocca P, et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol. 2007;20:303–9.

    Article  CAS  PubMed  Google Scholar 

  • Brunelli M, Eccher A, Gobbo S, et al. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma. Mod Pathol. 2008;21:1–6.

    Article  CAS  PubMed  Google Scholar 

  • Capitanio U, Montorsi F. Renal cancer. Lancet 2015.

    Google Scholar 

  • Chen YB, Brannon AR, Toubaji A, et al. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol. 2014;38:627–37.

    Article  PubMed Central  PubMed  Google Scholar 

  • Cheng L, Gu J, Eble JN, et al. Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomas. Am J Surg Pathol. 2001;25:1231–6.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, MacLennan GT, Zhang S, et al. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Clin Cancer Res. 2008;14:8087–93.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol. 2009;40:10–29.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Williamson SR, Zhang S, et al. Molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy. Expert Rev Anticancer Ther. 2010a;10:843–64.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Williamson SR, Zhang S, Maclennan GT, Montironi R, Lopez-Beltran A. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy. Expert Rev Anticancer Ther. 2010b;10:843–64.

    Article  CAS  PubMed  Google Scholar 

  • Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol. 2006;19:488–93.

    Article  CAS  PubMed  Google Scholar 

  • Cossu-Rocca P, Eble JN, Zhang S, et al. Interphase cytogenetic analysis with centromeric probes for chromosome 1, 2, 6, 10, and 17 in eleven tumors from a patient with bilateral renal oncocytosis. Mod Pathol. 2008;21:498–504.

    Article  CAS  PubMed  Google Scholar 

  • Delahunt B, Sika-Paotonu D, Bethwaite PB, et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol. 2007;31:957–60.

    Article  PubMed  Google Scholar 

  • Delahunt B, Srigley JR. The evolving classification of renal cell neoplasia. Semin Diagn Pathol. 2015;32:90–102.

    Google Scholar 

  • Delahunt B, Srigley JR, Egevad L, Montironi R, International Society for Urological P. International Society of Urological Pathology grading and other prognostic factors for renal neoplasia. Eur Urol 2014;66:795–8.

    Google Scholar 

  • Diolombi ML, Cheng L, Argani P, Epstein JI. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential? Am J Surg Pathol 2015;39:1621–34.

    Google Scholar 

  • Eble JN. Mucinous tubular and spindle cell carcinoma and post-neuroblastoma carcinoma: newly recognized entities in the renal cell carcinoma family. Pathology. 2003;35:499–504.

    Article  PubMed  Google Scholar 

  • Eble JN, Amin MB, Young RH. Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol. 1997;21:1123–30.

    Article  CAS  PubMed  Google Scholar 

  • Ficarra V, Brunelli M, Cheng L, et al. Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors. Eur Urol. 2010;58:655–68.

    Article  PubMed  Google Scholar 

  • Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathological and molecular genetic entity. Am J Surg Pathol. 2008a;32:1239–45.

    Article  PubMed  Google Scholar 

  • Gobbo S, Eble JN, Huang J, et al. Schwannoma of the kidney. Mod Pathol. 2008b;21:779–83.

    Article  CAS  PubMed  Google Scholar 

  • Gobbo S, Eble JN, MacLennan GT, et al. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol. 2008c;32:1780–6.

    Article  PubMed  Google Scholar 

  • Gobbo S, Eble JN, Delahunt B, et al. Renal cell neoplasia of oncocytosis has distinct morphologic, immunohistochemical and cytogenetic profiles. Am J Surg Pathol. 2010;34:620–6.

    PubMed  Google Scholar 

  • Grignon D, Eble JN. Papillary and metanephric adenomas of the kidney. Semin Diagn Pathol. 1998;15:41–53.

    CAS  PubMed  Google Scholar 

  • Halat S, Eble JN, Grignon DG, et al. Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol. 2010;23:931–6.

    Article  PubMed  Google Scholar 

  • Hu Y, Hartmann A, Stoehr C, et al. PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody. J Clin Pathol. 2012;65:254–6.

    Article  PubMed  Google Scholar 

  • Jones JD, Eble JN, Wang M, et al. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinoma. Clin Cancer Res. 2005a;11:7226–33.

    Article  CAS  PubMed  Google Scholar 

  • Jones TD, Eble JN, Wang M, et al. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation. Cancer. 2005b;104:1195–203.

    Article  CAS  PubMed  Google Scholar 

  • Kinney SN, Eble JN, Hes O, et al. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma. Mod Pathol 2015;28:1236–48.

    Google Scholar 

  • Kum JB, Grignon DJ, Wang M, et al. Mixed epithelial and stromal tumors of the kidney: evidence for a single cell of origin with capacity for epithelial and stromal differentiation. Am J Surg Pathol. 2011;35:1114–22.

    Article  PubMed  Google Scholar 

  • Kunju LP, Wojno K, Wolf JS, et al. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol. 2008;39:96–101.

    Article  PubMed  Google Scholar 

  • Lopez-Beltran A, Carrasco JC, Cheng L, Scarpelli M, Kirkali Z, Montironi R. 2009 update on the classification of renal epithelial tumors in adults. Int J Urol. 2009;16:432–43.

    Article  PubMed  Google Scholar 

  • Lopez-Beltran A, Kirkali Z, Montironi R, et al. Unclassified renal cell carcinoma: a report of 56 cases. BJU Int. 2012;110:786–93.

    Article  PubMed  Google Scholar 

  • MacLennan GT, Cheng L. Tubulocystic carcinoma of the kidney. J Urol. 2011;185:2348–9.

    Article  PubMed  Google Scholar 

  • MacLennan GT, Farrow GM, Bostwick DG. Low grade collecting duct carcinoma of the kidney: report of 13 cases of low grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology. 1997;50:679–84.

    Article  CAS  PubMed  Google Scholar 

  • MacLennan GT, Ross J, Cheng L. Cystic partially differentiated nephroblastoma. J Urol. 2010;183:1585–6.

    Article  PubMed  Google Scholar 

  • Martignoni G, Brunelli M, Segala D, et al. Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations. Mod Pathol. 2014;27:765–74.

    Article  CAS  PubMed  Google Scholar 

  • Moch H, Humphrey PA, Ulbright TM, Reuter VE. (2016) Classification of Tumours of the Urinary System and Male Genital Organs. International Agency for Research on Cancer (IARC) Press, Lyon.

    Google Scholar 

  • Montironi R, Lopez-Beltran A, Cheng L, Galosi AB, Montorsi F, Scarpelli M. Clear cell renal cell carcinoma (ccRCC) with hemangioblastoma-like features: a previously unreported pattern of ccRCC with possible clinical significance. Eur Urol. 2014;66:806–10.

    Article  PubMed  Google Scholar 

  • Netto GJ, Cheng L. Emerging critical role of molecular testing in diagnostic genitourinary pathology. Arch Pathol Lab Med. 2012;136:372–90.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rao Q, Liu B, Cheng L, et al. Renal cell carcinomas with t(6;11)(p21;q12): a clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization. Am J Surg Pathol. 2012;36:1327–38.

    Article  PubMed  Google Scholar 

  • Rao Q, Cheng L, Xia QY, et al. Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas. Histopathology. 2013a;62:642–50.

    Article  PubMed  Google Scholar 

  • Rao Q, Williamson SR, Zhang S, et al. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Am J Surg Pathol. 2013b;37:804–15.

    Article  PubMed  Google Scholar 

  • Reuter VE, Argani P, Zhou M, Delahunt B, Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group . Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38:e35–49.

    Google Scholar 

  • Shuch B, Amin A, Armstrong AJ, et al. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol 2015;67:85–97.

    Google Scholar 

  • Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37:1469–89.

    Article  PubMed  Google Scholar 

  • Tacha D, Qi W, Zhou D, Bremer R, Cheng L. PAX8 mouse monoclonal antibody [BC12] recognizes a restricted epitope and is highly sensitive in renal cell and ovarian cancers but does not cross-react with B cells and tumors of pancreatic origin. Appl Immunohistochem Mol Morphol. 2013;21:59–63.

    Google Scholar 

  • Tan PH, Cheng L, Rioux-Leclercq N, et al. Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol. 2013;37:1518–31.

    Article  PubMed Central  PubMed  Google Scholar 

  • Tran T, Jones CL, Williamson SR, et al. Tubulocystic renal cell carcinoma is an entity immunohistochemically and genetically distinct from papillary renal cell carcinoma. Histopathology 2016 (in press).

    Google Scholar 

  • Tran T, Sundaram CP, Bahler CD, et al. Correcting the Shrinkage Effects of Formalin Fixation and Tissue Processing for Renal Tumors: toward Standardization of Pathological Reporting of Tumor Size. J Cancer 2015;6:759–66.

    Google Scholar 

  • Wilkerson ML, Lin F, Liu H, Cheng L. The application of immunohistochemical biomarkers in urologic surgical pathology. Arch Pathol Lab Med. 2014;138:1643–65.

    Article  PubMed  Google Scholar 

  • Williamson SR, Cheng L. Do clear cell papillary renal cell carcinomas occur in patients with von Hippel-Lindau disease? Hum Pathol 2015;46:340–1.

    Google Scholar 

  • Williamson SR, Cheng L, Eble JN, et al. Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity. Mod Pathol 2015;28:279–94.

    Google Scholar 

  • Williamson SR, Eble JN, Cheng L, Grignon DJ. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol. 2013a;26:697–708.

    Article  CAS  PubMed  Google Scholar 

  • Williamson SR, Gupta NS, Eble JN, et al. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis. Am J Surg Pathol. 2015;39:1502–10.

    Google Scholar 

  • Williamson SR, MacLennan GT, Lopez-Beltran A, et al. Cystic partially regressed clear cell renal cell carcinoma: a potential mimic of multilocular cystic renal cell carcinoma. Histopathology. 2013b;63:767–79.

    Article  PubMed  Google Scholar 

  • Williamson SR, Zhang S, Eble JN, et al. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma. Am J Surg Pathol. 2013c;37:1131–9.

    Article  PubMed  Google Scholar 

  • Williamson SR, Cheng L, Eble JN, et al. Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity. Mod Pathol. 2015a;28:279–94.

    Article  CAS  PubMed  Google Scholar 

  • Williamson SR, Eble JN, Amin MB, et al. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol. 2015b;28:80–94.

    Article  CAS  PubMed  Google Scholar 

  • Yang P, Cornejo KM, Sadow PM, et al. Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol. 2014;38:895–909.

    Article  PubMed Central  PubMed  Google Scholar 

  • Zhao M, Williamson SR, Yu J, et al. PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis. Hum Pathol. 2013;44:2247–55.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University Hospitals Case Medical Center, Case Western Reserve School of Medicine, 2085 Adelbert Road, Cleveland, OH, 44106, USA

    Gregory T. MacLennan MD

  2. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

    Liang Cheng MD

Authors
  1. Gregory T. MacLennan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liang Cheng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Liang Cheng MD .

Editor information

Editors and Affiliations

  1. Indiana University School of Medicine, Indianapolis, Indiana, USA

    Liang Cheng

  2. Granger Diagnostics, A Division of Granger Genetics, North Chesterfield, Virginia, USA

    David G. Bostwick

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

MacLennan, G.T., Cheng, L. (2016). Neoplasms of the Kidney. In: Cheng, L., Bostwick, D. (eds) Essentials of Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-23380-2_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23380-2_35

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-23379-6

  • Online ISBN: 978-3-319-23380-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation